NCT07128355 2026-04-09
Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
Massachusetts General Hospital
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
29 trialsNCT06828588 2026-03-30
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07487402 2026-03-23
Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT07486492 2026-03-20
Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer
The First Affiliated Hospital of Xiamen University
Phase EARLY_PHASE1 Not yet recruiting
NCT07446257 2026-03-03
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07318389 2026-02-27
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07420010 2026-02-19
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT07394205 2026-02-06
Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer
First Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Not yet recruiting
NCT07389525 2026-02-05
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
Indiana University
Phase EARLY_PHASE1 Not yet recruiting
NCT06824363 2026-01-30
ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu
University of California, Irvine
Phase EARLY_PHASE1 Not yet recruiting
NCT07352345 2026-01-20
Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Not yet recruiting
NCT07231094 2025-11-17
A Clinical Study Evaluating the Safety, Tolerability, Preliminary Efficacy and Immunogenicity of a Tumor Vaccine Injection Targeting Stressinducible Proteins MICA/B in Combination With the AG Regimen in Patients With Metastatic Pancreatic Cancer
The Third Xiangya Hospital of Central South University
Phase EARLY_PHASE1 Not yet recruiting
NCT07166263 2025-09-10
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07026981 2025-08-08
[Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT06931873 2025-04-17
Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer
Changhai Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06887673 2025-03-20
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
University of South Florida
Phase EARLY_PHASE1 Not yet recruiting
NCT06756295 2025-03-12
FAST-CR
The University of Hong Kong-Shenzhen Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06646783 2024-10-17
Phase IIT Trial of SNA014
SmartNuclide Biopharma
Phase EARLY_PHASE1 Not yet recruiting
NCT06645301 2024-10-16
BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies
BioSyngen Pte Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT06645314 2024-10-16
Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma
BioSyngen Pte Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT06619886 2024-10-01
TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Not yet recruiting
NCT06525714 2024-07-31
Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer
The First Hospital of Jilin University
Phase EARLY_PHASE1 Not yet recruiting
NCT06434376 2024-05-30
MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis
Second Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Not yet recruiting
NCT06432075 2024-05-29
Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer
First Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Not yet recruiting
NCT06364800 2024-04-15
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody
Beijing 302 Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06196658 2024-01-09
Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer
First People's Hospital of Hangzhou
Phase EARLY_PHASE1 Not yet recruiting
NCT06173726 2023-12-18
Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer
BioSyngen Pte Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT06156267 2023-12-05
Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino
Fudan University
Phase EARLY_PHASE1 Not yet recruiting
NCT05447234 2023-02-16
TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting